{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:44:30Z","timestamp":1792658670007,"version":"4.5.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/ajg.2014.131","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T08:01:04Z","timestamp":1402992064000},"page":"950-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":632,"title":["ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury"],"prefix":"10.14309","volume":"109","author":[{"given":"Naga P","family":"Chalasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210210","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R4-7-20210210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40290-013-0015-5","article-title":"Drug-induced liver injury throughout the drug development life cycle: where we have been, where are we now, and where we are headed. Perspectives of a clinical hepatologist.","volume":"27","author":"Lewis","year":"2013","journal-title":"Pharm Med"},{"key":"R5-7-20210210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity.","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R7-7-20210210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"R8-7-20210210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"key":"R9-7-20210210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: from bedside to bench.","volume":"8","author":"Tujios","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-7-20210210","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States.","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"R11-7-20210210","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.20948","article-title":"Davern TJ et al. the ALFSG. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"R12-7-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hys law: predicting serious hepatotoxicity.","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-7-20210210","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States.","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"R17-7-20210210","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugsI. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"R18-7-20210210","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugsII. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"R19-7-20210210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"R20-7-20210210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cgh.2010.02.008","article-title":"Important elements for the diagnosis of drug-induced liver injury.","volume":"8","author":"Agarwal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-7-20210210","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","article-title":"Hepatitis E.","volume":"367","author":"Hoofnagle","year":"2012","journal-title":"N Engl J Med"},{"key":"R26-7-20210210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in healthy individuals.","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R27-7-20210210","first-page":"671","article-title":"Wilsons disease.","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"R28-7-20210210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"R30-7-20210210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation.","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transpl"},{"key":"R31-7-20210210","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"R32-7-20210210","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R33-7-20210210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R34-7-20210210","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archderm.143.12.1515","article-title":"Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.","volume":"143","author":"Berends","year":"2007","journal-title":"Arch Dermatol"},{"key":"R35-7-20210210","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2007.03330.x","article-title":"The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury.","volume":"25","author":"Bjornsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-7-20210210","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.22442","article-title":"Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.","volume":"48","author":"Rochon","year":"2008","journal-title":"Hepatology"},{"key":"R37-7-20210210","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"R38-7-20210210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/01926230590522356","article-title":"Recognizing drug-induced liver injury: current problems, possible solutions.","volume":"33","author":"Lee","year":"2005","journal-title":"Toxicol Pathol"},{"key":"R39-7-20210210","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a US multicenter, prospective study.","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"R40-7-20210210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure.","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"R41-7-20210210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R42-7-20210210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/lt.23370","article-title":"Comparison of the Sequential Organ Failure Assessment Score with the Kings College Hospital Criteria and the Model for End-Stage Liver Disease score for the prognosis of acetaminophen-induced acute liver failure.","volume":"18","author":"Cholongitas","year":"2012","journal-title":"Liver Transpl"},{"key":"R43-7-20210210","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1053\/j.gastro.2012.07.113","article-title":"ALF Study Group. Development of an accurate index for predicting outcomes of patients with acute liver failure.","volume":"143","author":"Rutherford","year":"2012","journal-title":"Gastroenterology"},{"key":"R44-7-20210210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2010.04.029","article-title":"Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.","volume":"53","author":"Bechmann","year":"2010","journal-title":"J Hepatology"},{"key":"R45-7-20210210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yrtph.2009.03.003","article-title":"Drug-induced liver injury following positive drug rechallenge.","volume":"54","author":"Papay","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"R47-7-20210210","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"key":"R48-7-20210210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-159-8-201310150-00005","article-title":"Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure.","volume":"159","author":"Saliba","year":"2013","journal-title":"Ann Intern Med"},{"key":"R49-7-20210210","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"key":"R53-7-20210210","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-156-12-201206190-00006","article-title":"Acute liver injury due to Flavocoxid (limbrel), a medical food for osteoarthritis. A case series.","volume":"156","author":"Chalasani","year":"2013","journal-title":"Ann Intern Med"},{"key":"R56-7-20210210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/pca.1264","article-title":"Phenolic composition and antioxidant properties of some traditionally used medicinal plants affected by the extraction time and hydrolysis.","volume":"22","author":"Komes","year":"2011","journal-title":"Phytochem Anal"},{"key":"R58-7-20210210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10528-012-9521-5","article-title":"Impact of geographic range on genetic and chemical diversity of Indian valerian (Valeriana jatamansi) from northwestern Himalaya.","volume":"50","author":"Sundaresan","year":"2012","journal-title":"Biochem Genet"},{"key":"R59-7-20210210","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/jf1028174","article-title":"Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses.","volume":"59","author":"Xiao","year":"2011","journal-title":"J Agric Food Chem"},{"key":"R60-7-20210210","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.ju.0000165187.31941.cd","article-title":"Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors.","volume":"174","author":"Fleshler","year":"2005","journal-title":"J Urol"},{"key":"R61-7-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2002-20060","article-title":"Microbial contamination of medicinal plants.","volume":"68","author":"Kneifel","year":"2000","journal-title":"Planta Med"},{"key":"R62-7-20210210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2008.08.017","article-title":"Severe hepatotoxicity following ingestion of Herbalife contaminated with Bacillus subtilis.","volume":"50","author":"Stickel","year":"2009","journal-title":"J Hepatol"},{"key":"R63-7-20210210","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00228-001-0400-y","article-title":"Heavy metals in traditional Indian remedies.","volume":"57","author":"Ernst","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R64-7-20210210","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.300.8.915","article-title":"Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold over the internet.","volume":"300","author":"Saper","year":"2008","journal-title":"JAMA"},{"key":"R65-7-20210210","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.161.6.805","article-title":"Americans views on the use and regulation of dietary supplements.","volume":"161","author":"Blendon","year":"2001","journal-title":"Arch Intern Med"},{"key":"R66-7-20210210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2008-1040724","article-title":"Hepatic lesions caused by anabolic and contraceptive steroids.","volume":"1","author":"Ishak","year":"1981","journal-title":"Semin Liver Dis"},{"key":"R67-7-20210210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/036354658401200613","article-title":"Anabolic steroids a review of the literature.","volume":"12","author":"Haupt","year":"1984","journal-title":"Am J Sports Med"},{"key":"R68-7-20210210","first-page":"4e468","article-title":"Cholestasis secondary to anabolic steroid use in young men.","volume":"34","author":"Elsharkawy","year":"2012","journal-title":"BMJ"},{"key":"R69-7-20210210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bmj.295.6591.183","article-title":"Veno-occlusive disease of the liver secondary to ingestion of comfrey.","volume":"295","author":"Weston","year":"1987","journal-title":"Br Med J"},{"key":"R70-7-20210210","first-page":"285","article-title":"Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica.","volume":"57","author":"Bras","year":"1954","journal-title":"AMA Arch Pathol"},{"key":"R71-7-20210210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","article-title":"Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids.","volume":"3","author":"Chojkier","year":"2003","journal-title":"J Hepatol"},{"key":"R72-7-20210210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0016-5085(19)32224-3","article-title":"Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona.","volume":"73","author":"Stillman","year":"1977","journal-title":"Gastroenterology"},{"key":"R73-7-20210210","first-page":"271","article-title":"An outbreak of hepatic veno-occlusive disease in North-Western Afghanistan.","volume":"2","author":"Mohabbat","year":"1976","journal-title":"Lancet"},{"key":"R74-7-20210210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","article-title":"An epidemic of veno-occlusive disease in Central India.","volume":"2","author":"Tandon","year":"1976","journal-title":"Lancet"},{"key":"R75-7-20210210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","article-title":"Burden of digestive diseases in the United States part 1: overall and upper gastrointestinal diseases.","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"R77-7-20210210","first-page":"64","article-title":"The burden of acute non-fulminant drug-induced hepatitis in a United States tertiary referral center.","volume":"39","author":"Galan","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R78-7-20210210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1572-0241.2006.01019.x","article-title":"Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States.","volume":"102","author":"Vuppalanchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R79-7-20210210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and Causality Assessment in Drug-Induced liver Injury: Summary of a Clinical Research Workshop.","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"R80-7-20210210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of non-alcoholic fatty liver: Practice guideline by the American Association of the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterology Association.","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R81-7-20210210","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of Genotype 1 chronic hepatitis C virus infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases.","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"R82-7-20210210","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Prescribing medications in patients with cirrhosis - a practical guide.","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R83-7-20210210","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.","volume":"128","author":"Chalasani","year":"2004","journal-title":"Gastroenterology"},{"key":"R84-7-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000441-200502000-00002","article-title":"Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity form lovastatin than those with normal baseline liver enzymes.","volume":"329","author":"Vuppalanchi","year":"2005","journal-title":"Am J Med Sci"},{"key":"R85-7-20210210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","article-title":"Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled multicenter trial.","volume":"46","author":"Lewis","year":"2007","journal-title":"Hepatology"},{"key":"R86-7-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.6.1.1","article-title":"Tamoxifen-induced nonalcoholic steatohepatitis: where are we now and where are we going?","volume":"6","author":"Osman","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"R87-7-20210210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9343(91)90667-M","article-title":"Methotrexate and histological hepatic abnormalities: A meta-analysis.","volume":"90","author":"Whiting-OKeefe","year":"1991","journal-title":"Am J Med"},{"key":"R88-7-20210210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2005.12.014","article-title":"An assessment of statin safety by hepatologists.","volume":"97","author":"Cohen","year":"2006","journal-title":"Am J Cardiol"},{"key":"R89-7-20210210","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"R90-7-20210210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/jvh.12085","article-title":"A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype 1 hepatitis C patients.","volume":"20","author":"Bader","year":"2013","journal-title":"J Viral Hepatitis"},{"key":"R91-7-20210210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults with human immunodeficiency virus and the role of hepatitis C or B virus infection.","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"R92-7-20210210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.23716","article-title":"Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.","volume":"52","author":"Nunez","year":"2010","journal-title":"Hepatology"},{"key":"R93-7-20210210","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Anti-tuberculosis drug-induced hepatotoxicity: the role of hepatitis C virus and the HIV.","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Resp Crit Care Med"},{"key":"R94-7-20210210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.510310129","article-title":"Anti-tuberculosis drug-related liver dysfunction in chronic hepatitis B infection.","volume":"31","author":"Wong","year":"2000","journal-title":"Hepatology"},{"key":"R95-7-20210210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/lt.23424","article-title":"Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.","volume":"18","author":"Sembera","year":"2012","journal-title":"Liver Transpl"},{"key":"R96-7-20210210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.","volume":"338","author":"Vento","year":"1998","journal-title":"N Eng J Med"},{"key":"R97-7-20210210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R98-7-20210210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/jhep.2001.21083","article-title":"Causality assessment versus guilt-by-association in drug hepatotoxicity.","volume":"33","author":"Kaplowitz","year":"2001","journal-title":"Hepatology"},{"key":"R99-7-20210210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity.","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2014131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2014131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2014131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201407000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:49:36Z","timestamp":1786542576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201407000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2014.131","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}